Anesthesia Drugs Market Research Report - Forecast To 2027

Anesthesia Drugs Market information, by type of anesthesia (General Anesthesia, Regional Anesthesia, Local Anesthesia, and others), by Types of Drugs (General Anesthetics, Local Anesthetics, and others), by Route of administration (inhalation, intravenous, and others) - Forecast to 2027

ID: MRFR/Pharma/1868-HCR | February 2021 | Region: Global | 85 pages

Market Synopsis of Anesthesia Drugs Market:


Global Anesthesia Drugs Market is growing steadily. Anesthesia is the process of prevention or reduction of the feeling of pain or sensation during surgery or other painful medical procedures. It induced loss of sensation or awareness. An anesthetic drug is used to prevent pain during surgery. Types and degree of an anesthesia may vary for surgeries and patient condition. There are three main types of anesthesia i.e. general anesthesia, local anesthesia and regional anesthesia. Global Anesthesia Drugs Market is expected to grow at the average CAGR of 3.7% during 2015-2022. Global Anesthesia Drugs Market is expected to grow US$ 4.9 billion by 2022 from US$ 3.1 billion in 2015. However, several side effects of anesthesia, regulatory issues and lack of skilled anesthesiologist are the major restraints for the market. 

 

Key Players for Global Anesthesia Drugs Market:                                      

 

Some of the key players in this market are: 


  • Abbott Laboratories (US)

  • Astrazeneca PLC (British–Swedish)

  • Baxter International Inc. (US)

  • Hospira, Inc. (US)

  • F. Hoffmann-La Roche Ltd. (Switzerland)

  • Hikma Pharmaceuticals PLC (UK)

  • AbbVie Inc. (US)

  • Fresenius Se & Co. Kgaa (Germany)


Anesthesia Drugs Market Segments:       

Anesthesia Drugs Market has been segmented on the basis of types of anesthesia which comprises General Anesthesia, Regional Anesthesia, Local Anesthesia, and others. On the basis of type of drugs it segmented into General Anesthetics, Local Anesthetics, and others. On the basis of Route of administration the market is segmented into inhalation, intravenous, and others. Global Anesthesia Drugs Market by Types of Anesthesia: Global Anesthesia Drugs Market

Study objectives of Global Anesthesia Drugs Market:



  • To provide detailed analysis of the market structure along with forecast for the next 5 years of the various segments and sub-segments of the Global Anesthesia Drugs Market

  • To provide insights about factors affecting the market growth

  • To analyze the Global Anesthesia Drugs Market based on various factors - price analysis, supply chain analysis, porters five force analysis etc.

  • To provide historical and forecast revenue of the market segments and sub-segments with respect to four main geographies and their countries- Americas, Europe, Asia-Pacific, and Middle East & Africa.

  • To provide country level analysis of the market with respect to the current market size and future prospective

  • To provide country level analysis of the market for segments by type and its sub-segments.

  • To provide overview of key players and their strategic profiling in the market, comprehensively analyzing their core competencies, and drawing a competitive landscape for the market

  • To track and analyze competitive developments such as joint ventures, strategic alliances, mergers and acquisitions, new product developments, and research and developments in the Global Anesthesia Drugs Market



Regional Analysis of Global Anesthesia Drugs Market:                        

 

Considering the global scenario of the market, North America region is believed to be the largest market for Anesthesia Drugs. Moreover the European market is also growing and second largest market for Anesthesia Drugs. On the other hand, Asia-Pacific market is expected to grow at significant rate in the Anesthesia Drugs during the forecasted period. Rest of the World is likely to have a limited but steady growth in the market.

Global Anesthesia Drugs Market, by Region



  • Americas


    • North America


      • US

      • Canada


    • Latin America


  • Europe


    • Western Europe


      • Germany

      • France

      • Italy

      • Spain

      • UK

      • Rest of Western Europe


    • Eastern Europe


  • Asia-Pacific


    • Japan

    • China

    • India

    • Australia

    • South Korea

    • Rest of Asia-Pacific


  • The Middle East & Africa


    • Middle East

    • Africa





 

Intended Audience:



  • Hospitals and Clinics

  • Anesthesia Drugs manufacturers and suppliers

  • Government and Independent Regulatory Authorities

  • Research and Development (R&D) Companies

  • Market Research and Consulting Service Providers

  • Medical Research Laboratories

  • Potential Investors




The report for Global Anesthesia Drugs Market of Market Research Future comprises extensive primary research along with the detailed analysis of qualitative as well as quantitative aspects by various industry experts, key opinion leaders to gain the deeper insight of the market and industry performance. The report gives the clear picture of current market scenario which includes historical and projected market size in terms of value and volume, technological advancement, macro economical and governing factors in the market. The report provides details information and strategies of the top key players in the industry. The report also gives a broad study of the different markets segments and regions



Report Scope:
Report Attribute/Metric Details
  Market Size   US$ 4.9 billion
  CAGR   2015-2022: 3.7%
  Base Year   2019
  Forecast Period   2027
  Historical Data   2018
  Forecast Units   Value (USD Billion)
  Report Coverage   Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
  Segments Covered   Type of anesthesia, Types of Drugs, Route of administration
  Geographies Covered   North America, Europe, Asia-Pacific, and Rest of the World (RoW)
  Key Vendors   Abbott Laboratories (US), Astrazeneca PLC (British–Swedish), Baxter International Inc. (US), Hospira, Inc. (US), F. Hoffmann-La Roche Ltd. (Switzerland), Hikma Pharmaceuticals PLC (UK), AbbVie Inc. (US), Fresenius Se & Co. Kgaa (Germany)
  Key Market Opportunities   New product developments
  Key Market Drivers

  • Prevention or reduction of the feeling of pain
  • Prevent pain during surgery


  • Frequently Asked Questions (FAQ) :


    anesthesia drugs market is projected grow at approximately 3.7% CAGR during the assessment period (2016-2022).

    The valuation of the global anesthesia drugs market is estimated to increase to USD 4.9 BN by the end of 2022.

    Rise in various kinds of surgeries and patient condition and increasing awareness and rising focus on health management are the major tailwinds pushing the growth of the global anesthesia drugs market.

    North America holds the largest share in the global anesthesia drugs market, followed by Europe and the Asia Pacific, respectively.

    Abbott Laboratories (USA), AbbVie Inc. (USA), AstraZeneca PLC (British–Swedish), F. Hoffmann-La Roche Ltd. (Switzerland), Baxter International Inc. (USA), Fresenius Se & Co. KGA (Germany), Hospira, Inc. (USA), and Hikma Pharmaceuticals PLC (UK), are some of the major players operating in the anesthesia drugs market.

    BRIEF TOC

    1. Report Prologue

    2. Introduction

    2.1 Definition

    2.2 Scope of the Study

    2.2.1 Research Objective

    2.2.2 Assumptions

    2.2.3 Limitations

    2.3 Market Structure

    2.4. Market Segmentation

    3. Research Methodology

    3.1 Research Process

    3.2 Primary Research

    3.3 Secondary Research

    3.4 Market Size Estimation

    3.5 Forecast Model

    4. Market Dynamics

    4.1 Drivers

    4.2 Restraints

    4.3 Opportunities

    4.4 Mega Trends

    4.5 Macroeconomic Indicators

    5. Market Factor Analysis

    5.1 Value Chain Analysis

    5.2 PORTERS Five Forces

    5.3 demand & supply: gap analysis

    5.4 Pricing Analysis

    5.5 Investment Opportunity Analysis

    5.6 Merger and Acquisition Landscape

    5.9 Upcoming trends

    5.9.1 Market trends

    5.9.2 Technological trends

    5.9.3 Insurance & Regulations

    5.9.4 Others

    6. Anesthesia Drugs Market by Anesthesia Type

    7. Anesthesia Drugs Market by Type of Drugs

    8. Anesthesia Drugs Market by Route of administration

    9. Anesthesia Drugs Market by Region

    9.1 Introduction

    9.2 America

    9.2.1 North America

    9.2.1.1 The US

    9.2.1.2 Canada

    9.2.2 South America

    9.3 Europe

    9.3.1 Western Europe

    9.3.1.1Germany

    9.3.1.2 France

    9.3.1.3 Italy

    9.3.1.3 Spain

    9.3.1.5 UK

    9.3.1.6 Rest of Western Europe

    9.3.2 Eastern Europe

    9.4 Asia

    9.4.1 China

    9.4.2 India

    9.4.3 Japan

    9.4.4 South Korea

    9.4.5 Rest of Asia

    9.5 Pacific

    9.6 Rest of the World (RoW)